SCHEMBL4529707

SCHEMBL4529707

CC(C)(C)OC(=O)N1CCC2CN(C(=O)c3ccc4c(c3)CCN(C(=O)C3CCCCC3)C4)CC21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 4/20 0.52
KEAP1 Q14145 1/20 0.47
ALDH1A1 P00352 1/20 0.45
ESR2 Q92731 1/20 0.44
NR1H2 P55055 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40
SPR P35270 1/20 0.40
USP30 Q70CQ3 1/20 0.40
ABL1 P00519 1/20 0.39
RIN1 Q13671 1/20 0.39
NR1H3 Q13133 1/20 0.39
ENPP2 Q13822 1/20 0.39
UCHL1 P09936 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4D Q08499 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4436390 0.89 HDAC6 (0.58) HDAC6KEAP1ALDH1A1ESR2NR1H2
SCHEMBL4529315 0.83 HDAC6 (0.55) HDAC6KEAP1ALDH1A1ESR2NR1H2
SCHEMBL4516749 0.81 HDAC6 (0.58) HDAC6KEAP1ALDH1A1CYP1A2CYP3A4
SCHEMBL4516751 0.79 HDAC6 (0.56) HDAC6KEAP1ALDH1A1CYP1A2CYP3A4
SCHEMBL4431710 0.78 HDAC6 (0.64) HDAC6KEAP1ALDH1A1CYP1A2CYP3A4
SCHEMBL4521483 0.77 HDAC6 (0.61) HDAC6KEAP1ALDH1A1CYP1A2CYP3A4
SCHEMBL7438496 0.77 ESR2 (0.55) HDAC6ALDH1A1ESR2NR1H2NPC1
SCHEMBL7438486 0.77 ESR2 (0.55) HDAC6ALDH1A1ESR2NR1H2NPC1
SCHEMBL4507993 0.76 HDAC6 (0.62) HDAC6KEAP1ALDH1A1CYP1A2CYP3A4
SCHEMBL4505068 0.74 ESR2 (0.66) HDAC6ALDH1A1ESR2NR1H2ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099158-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099158-A1 TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR HRH3, HRH4, HRH1 HDAC6 848/4885KEAP1 909/4885ALDH1A1 3918/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.